By activating GLP-1 receptors, semaglutide stimulates insulin secretion, inhibits glucagon secretion, and slows down gastric emptying
S2CID 43716740
View image online ( Older woman with obesity and glasses Evidence is mounting that glucagon-like peptide-1 (GLP-1) receptor agonist drugs used to treat diabetes and obesity have protective effects across numerous organ systems
"All of a sudden I paused it, and I was like 'who is f is that?' You see it and you're like, 'Well, she's about to die of a heart attack,'" she recalled on "The Kelly Clarkson Show." She Didn't Realize How Much She'd Changed Clarkson added, "It's a weird thing
Several potential mechanisms have been proposed, though evidence specifically linking them to panic symptoms with Wegovy is limited: Increased heart rate : GLP-1 receptor agonists can increase heart rate, which may be perceived as anxiety or palpitations Hypoglycaemia : Though uncommon with Wegovy alone in people without diabetes, low blood sugar can trigger anxiety-like symptoms (risk increases if taking insulin or sulfonylureas) Gastrointestinal distress : Severe nausea or abdominal discomfort may provoke anxiety or panic responses in susceptible individuals Individual susceptibility varies considerably
A., Ozojide, K
